Developments FDA certifies LSL’s ophthalmic ointment manufacturing for U.S. market LSL Pharma (TSXV: LSL) has announced that the FDA has certified the ophthalmic ointment manufacturing operations of its subsidiary, Steri-Med Pharma, clearing the company to commercialize ophthalmic ointment products in... January 28, 2026